• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors





Emily Gillen, MA

Latest:

Emergency Department Visits for Nonurgent Conditions: Systematic Literature Review

This article presents a systematic review of the US literature on factors influencing the decision to visit the emergency department for nonurgent conditions.


Siyan Zhan, MD, PhD

Latest:

Type 2 Diabetes Mellitus in China: A Preventable Economic Burden

Treatment of type 2 diabetes mellitus and its complications places a heavy burden on healthcare budgets in China and will continue to do so.


Victoria Shier, MA

Latest:

How Will Provider-Focused Payment Reform Impact Geographic Variation in Medicare Spending?

Unlike ACOs or P4P, implementation of bundled payment for inpatient and post acute care in Medicare would modestly reduce geographic variation in spending.



Robert J. Sanchez, PhD

Latest:

Impact of Celecoxib Restrictions in Medicare Beneficiaries With Arthritis

A formulary restriction policy in a Medicare population was associated with lower celecoxib utilization; however, higher gastrointestinal- and arthritis-related medical costs were observed.



James W. Shaw, PhD, PharmD, MPH

Latest:

An Expanded Portfolio of Survival Metrics for Assessing Anticancer Agents

A novel, simplified cost-value analysis tool was created to better differentiate the value of anticancer agents and further characterize the expected survival benefit of all patients.




Marek S. Poniewierski, MD, MS

Latest:

Variation in the Cost of Medications for the Treatment of Colorectal Cancer

Using data from a nationwide registry, this study revealed significant variation in the use and cost of contemporary regimens for colorectal cancer.


Barsam Kasravi, MD, MPH

Latest:

Does CAC Testing Alter Downstream Treatment Patterns for Cardiovascular Disease?

This article provides an assessment of the downstream impact of coronary artery calcium scanning on the subsequent treatment patterns of non—high-risk patients.



Kiemanh Pham, MD, MPH

Latest:

A Revised Classification Algorithm for Assessing Emergency Department Visit Severity of Populations

An updated emergency visit classification tool enables managers to make valid inferences about levels of appropriateness of emergency department utilization and healthcare needs within a population.



Richard L. Barron, MS

Latest:

Validated Prediction of Imminent Risk of Fracture for Older Adults

This study provides proof of concept that imminent risk of fracture can be assessed by evaluating recent fracture, age, sex, race, medically significant falls, and psychoactive medications.


James B. Rebitzer, PhD

Latest:

Care Fragmentation, Quality, and Costs Among Chronically Ill Patients

Increased care fragmentation among chronically ill, commercially insured patients is associated with higher costs and lower quality of care.



John W. Finney, PhD

Latest:

Care Coordination to Increase Referrals to Smoking Cessation Telephone Counseling: A Demonstration Project

An intervention to increase tobacco treatment rates through care coordination for telephone counseling was effective in raising referral rates and in achieving excellent long-term abstinence.



Justin Blackburn, PhD

Latest:

The Relationship Between Preventive Dental Care and Overall Medical Expenditures

Using an instrumental variable approach, this study is the first to present causal estimates of the effect of preventive dental visits on overall medical expenditures.


Saul Shiffman, PhD

Latest:

A Cost-Effectiveness Analysis of Over-the-Counter Statins

This paper estimates the costs and benefits of over-the-counter (OTC) statins using data on statin use and cardiovascular risk, clinical studies of statin safety and efficacy, and an OTC statin use trial.


Elizabeth A. Chrischilles, PhD

Latest:

Stimulating Comprehensive Medication Reviews Among Medicare Part D Beneficiaries

This article describes a study of an intervention to engage Medicare Part D beneficiaries in obtaining a comprehensive medication review.






© 2024 MJH Life Sciences
AJMC®
All rights reserved.